The 2011 Traumatic Brain Injury Conference will bring together individuals from industry, government and academia to discuss the challenges and opportunities facing those involved in the research and development of new therapies for acute and chronic TBI. The Conference will take place March 7, 2011 in Washington, DC.
Key Questions Addressed by this Conference Include:
- How can animal model results translate to clinical research?
- What are the key patient populations for future clinical trials?
- What outcomes should new clinical trials measure?
- How can the blood-brain barrier be overcome in drug delivery?
Topics to be discussed Include:
- Animal models and TBI: translating results to the clinic
- Designing effective clinical trials, taking into account prognostic factors and likely clinical outcomes
- Drug delivery (blood-brain barrier) challenges facing developers of TBI therapies
- Acute TBI
- Post-Acute/chronic neurorehabilitation
- Neuroprotection
- Halting secondary injury in TBI
- Proper diagnosis – biomarkers and molecular diagnostics in TBI